| Alternatives to clopidogrel for acute coronary syndromes: Prasugrel or ticagrelor? | |
| | |
MedLine Citation:
|
PMID: 21160730 Owner: NLM Status: In-Data-Review |
Abstract/OtherAbstract:
|
Clopidogrel is a mainstay in the treatment of patients with acute coronary syndromes or those receiving endovascular prostheses. However, its efficacy has been challenged in the recent past by studies suggesting variable individual responsiveness and by new, more potent competitors, such as prasugrel and ticagrelor. But what is the actual body of evidence in support of clopidogrel? Is there any dark side of the moon? What is the role of prasugrel, which has already been approved in Europe and in the United States? And what will be the future role of ticagrelor, when approved for routine clinical practice? We hereby concisely summarize the scope of this clinical choice, providing arguments in favor and against each of the three antiplatelet agents: clopidogrel, prasugrel, and ticagrelor. |
| | |
Authors:
|
Giuseppe Biondi-Zoccai; Marzia Lotrionte; Fiorenzo Gaita |
Publication Detail:
|
Type: Journal Article |
Journal Detail:
|
Title: World journal of cardiology Volume: 2 ISSN: 1949-8462 ISO Abbreviation: World J Cardiol Publication Date: 2010 Jun |
Date Detail:
|
Created Date: 2010-12-16 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 101537090 Medline TA: World J Cardiol Country: China |
Other Details:
|
Languages: eng Pagination: 131-4 Citation Subset: - |
Affiliation:
|
Giuseppe Biondi-Zoccai, Marzia Lotrionte, Fiorenzo Gaita, Division of Cardiology, University of Turin, San Giovanni Battista "Molinette" Hospital, 10126 Turin, Italy; Unit for Heart Failure and Cardiac Rehabilitation, Catholic University, 00136 Rome, Italy. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Diagnosis and endoscopic treatment of esophago-bronchial fistula due to gastric heterotopy.
Next Document: Aortic stenosis: An update.